Market Cap 44.43B
Revenue (ttm) 6.07B
Net Income (ttm) 1.07B
EPS (ttm) N/A
PE Ratio 29.61
Forward PE 26.69
Profit Margin 17.69%
Debt to Equity Ratio 0.06
Volume 5,075,300
Avg Vol 5,056,202
Day's Range N/A - N/A
Shares Out 575.80M
Stochastic %K 38%
Beta 0.87
Analysts Strong Sell
Price Target $97.46

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provide...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 250 2500
Address:
One Edwards Way, Irvine, United States
BillionerOfKing
BillionerOfKing May. 11 at 3:44 PM
$EW Current Stock Price: $76.86 Contracts to trade: $77.5 EW May 15 2026 Call Entry: $0.25 Exit: $0.48 ROI: 91% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 10:13 PM
$EW Current Stock Price: $83.17 Contracts to trade: $82.5 EW May 15 2026 Call Entry: $1.70 Exit: $2.87 ROI: 69% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
CapitalMonk
CapitalMonk May. 4 at 11:52 AM
$EW Price: $83.98 (+0.57%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.74% RSI: 65.6 | Momentum: Strong Momentum Volume: +14.3% vs avg Volatility: 2.04% Support: $77.10 | Resistance: $85.06 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
NorthStarStats
NorthStarStats Apr. 26 at 5:12 PM
The top scores from the momentum scanner. When the overall scores are this low, the failure rate for momentum stocks is high. Setups to watch and study, Not trade recommendations. Approach Monday with extreme caution. Momentum is building in some of these names, but the environment isn't quite right. $EW Score 100, $NEM Score 73, $SLM Score 71, $AMP Score 70, $NDAQ Score 70
0 · Reply
harmongreg
harmongreg Apr. 26 at 4:08 PM
Dragonfly Capital - 5 Trade Ideas for Monday: Edwards Lifesciences, Halliburton, Nasdaq, NVIDIA and Patterson-UTI Energy $EW $HAL $NDAQ $NVDA $PTEN https://dragonflycap.com/5-trade-ideas-for-monday-edwards-lifesciences-halliburton-nasdaq-nvidia-and-patterson-uti-energy/
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Apr. 26 at 8:11 AM
$EW trading at $84 with 170% above-average volume, while $MDXG at $3 with 88% volume surge. EW showing strength compared to MDXG. MedicalTech sector heating up - will the trend continue?
0 · Reply
AXLFI_HQ
AXLFI_HQ Apr. 25 at 2:49 PM
$EW Healthcare providers and medical device manufacturers report strong Q1 2026 earnings driven by procedure volume growth, system placements, and margin expansion from operational efficiency. Learn more: https://axlfi.com/themes/220
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Apr. 25 at 11:04 AM
$EW looks good into next week
0 · Reply
XxGodFatherxX
XxGodFatherxX Apr. 24 at 1:44 PM
$EW 💩
0 · Reply
kcphaeton
kcphaeton Apr. 24 at 1:45 AM
$EW I made this comment back in October 2025. We really haven’t made a whole lot of progress but probably now that we have guidance in a positive manner. Maybe we can start climbing back to the all-time high which was around $130. Probably will take 12 to 18 months to get there. 
0 · Reply
Latest News on EW
Edwards Lifesciences appoints Theodora Mistras as CFO

2026-05-04T20:47:54.000Z - 8 days ago

Edwards Lifesciences appoints Theodora Mistras as CFO


Edwards Lifesciences Announces Appointment of CFO

May 4, 2026, 4:45 PM EDT - 8 days ago

Edwards Lifesciences Announces Appointment of CFO


Edwards Lifesciences Earnings Call Transcript: Q1 2026

Apr 23, 2026, 5:00 PM EDT - 19 days ago

Edwards Lifesciences Earnings Call Transcript: Q1 2026


Edwards Lifesciences sees Q2 EPS 70c-76c, consensus 75c

2026-04-23T20:30:33.000Z - 19 days ago

Edwards Lifesciences sees Q2 EPS 70c-76c, consensus 75c


Edwards Lifesciences reports Q1 EPS 78c, consensus 73c

2026-04-23T20:21:04.000Z - 19 days ago

Edwards Lifesciences reports Q1 EPS 78c, consensus 73c


Edwards Lifesciences Reports First Quarter Results

Apr 23, 2026, 4:15 PM EDT - 19 days ago

Edwards Lifesciences Reports First Quarter Results


Edwards Lifesciences announces new data on EVOQUE TTVR system

2026-03-30T14:12:36.000Z - 6 weeks ago

Edwards Lifesciences announces new data on EVOQUE TTVR system


Edwards Lifesciences Earnings Call Transcript: Q4 2025

Feb 10, 2026, 5:00 PM EST - 3 months ago

Edwards Lifesciences Earnings Call Transcript: Q4 2025


Edwards Lifesciences Reports Fourth Quarter Results

Feb 10, 2026, 4:15 PM EST - 3 months ago

Edwards Lifesciences Reports Fourth Quarter Results


Edwards Comments on JenaValve Acquisition

Jan 9, 2026, 6:48 PM EST - 4 months ago

Edwards Comments on JenaValve Acquisition


Edwards Lifesciences Transcript: Investor Day 2025

Dec 4, 2025, 8:30 AM EST - 5 months ago

Edwards Lifesciences Transcript: Investor Day 2025


Top small-cap plays for 2026

Nov 25, 2025, 1:24 PM EST - 6 months ago

Top small-cap plays for 2026

A COHR DG TXT VLO


Edwards Lifesciences Earnings Call Transcript: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 6 months ago

Edwards Lifesciences Earnings Call Transcript: Q3 2025


Edwards Lifesciences CFO Scott Ullem to step down by mid-2026

Oct 30, 2025, 4:38 PM EDT - 6 months ago

Edwards Lifesciences CFO Scott Ullem to step down by mid-2026


Edwards Lifesciences Announces CFO Transition Plan

Oct 30, 2025, 4:15 PM EDT - 6 months ago

Edwards Lifesciences Announces CFO Transition Plan


Edwards Lifesciences Reports Third Quarter Results

Oct 30, 2025, 4:13 PM EDT - 6 months ago

Edwards Lifesciences Reports Third Quarter Results


Edwards Lifesciences Transcript: Investor Update

Oct 27, 2025, 9:00 PM EDT - 7 months ago

Edwards Lifesciences Transcript: Investor Update


Edwards Lifesciences Earnings Call Transcript: Q2 2025

Jul 24, 2025, 5:00 PM EDT - 10 months ago

Edwards Lifesciences Earnings Call Transcript: Q2 2025


Edwards Lifesciences Reports Second Quarter Results

Jul 24, 2025, 4:15 PM EDT - 10 months ago

Edwards Lifesciences Reports Second Quarter Results


Trade Tracker: Bill Baruch buys Edwards Lifesciences

May 19, 2025, 2:13 PM EDT - 1 year ago

Trade Tracker: Bill Baruch buys Edwards Lifesciences


BillionerOfKing
BillionerOfKing May. 11 at 3:44 PM
$EW Current Stock Price: $76.86 Contracts to trade: $77.5 EW May 15 2026 Call Entry: $0.25 Exit: $0.48 ROI: 91% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 10:13 PM
$EW Current Stock Price: $83.17 Contracts to trade: $82.5 EW May 15 2026 Call Entry: $1.70 Exit: $2.87 ROI: 69% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
CapitalMonk
CapitalMonk May. 4 at 11:52 AM
$EW Price: $83.98 (+0.57%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.74% RSI: 65.6 | Momentum: Strong Momentum Volume: +14.3% vs avg Volatility: 2.04% Support: $77.10 | Resistance: $85.06 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
NorthStarStats
NorthStarStats Apr. 26 at 5:12 PM
The top scores from the momentum scanner. When the overall scores are this low, the failure rate for momentum stocks is high. Setups to watch and study, Not trade recommendations. Approach Monday with extreme caution. Momentum is building in some of these names, but the environment isn't quite right. $EW Score 100, $NEM Score 73, $SLM Score 71, $AMP Score 70, $NDAQ Score 70
0 · Reply
harmongreg
harmongreg Apr. 26 at 4:08 PM
Dragonfly Capital - 5 Trade Ideas for Monday: Edwards Lifesciences, Halliburton, Nasdaq, NVIDIA and Patterson-UTI Energy $EW $HAL $NDAQ $NVDA $PTEN https://dragonflycap.com/5-trade-ideas-for-monday-edwards-lifesciences-halliburton-nasdaq-nvidia-and-patterson-uti-energy/
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Apr. 26 at 8:11 AM
$EW trading at $84 with 170% above-average volume, while $MDXG at $3 with 88% volume surge. EW showing strength compared to MDXG. MedicalTech sector heating up - will the trend continue?
0 · Reply
AXLFI_HQ
AXLFI_HQ Apr. 25 at 2:49 PM
$EW Healthcare providers and medical device manufacturers report strong Q1 2026 earnings driven by procedure volume growth, system placements, and margin expansion from operational efficiency. Learn more: https://axlfi.com/themes/220
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Apr. 25 at 11:04 AM
$EW looks good into next week
0 · Reply
XxGodFatherxX
XxGodFatherxX Apr. 24 at 1:44 PM
$EW 💩
0 · Reply
kcphaeton
kcphaeton Apr. 24 at 1:45 AM
$EW I made this comment back in October 2025. We really haven’t made a whole lot of progress but probably now that we have guidance in a positive manner. Maybe we can start climbing back to the all-time high which was around $130. Probably will take 12 to 18 months to get there. 
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 23 at 8:25 PM
$EW Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.66 up 8.20% YoY • Reported revenue of $1.65B up 16.70% YoY • Edwards Lifesciences is raising its full-year 2026 constant currency sales growth guidance to 9% to 11% and adjusted EPS guidance midpoint to $2.95-$3.05. The company projects Q2 2026 total sales between $1.66 and $1.74 billion.
0 · Reply
Estimize
Estimize Apr. 23 at 3:00 PM
$EW reports after the close, Estimize Consensus -0.01 EPS and +16.05M Revs compared to WS http://www.estimize.com/ew/fq1-2026?utm_content=p
0 · Reply
SparkyReturns
SparkyReturns Apr. 14 at 2:38 PM
$ICU I think they'll be fine with rolling out the SCD for AKI with Fresenius, but I hope they get another partner for the LVAD indication or another cytokine storm indication, that would be amazing. That's also a multi-Billion $ TAM. Someone like Medtronic, Edwards, Abbot, or Boston Scientific. GL longs! We are at the inflection point. $MDT $EW $ABT $BSX
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 13 at 3:05 PM
$EW RSI: 32.25, MACD: -1.0030 Vol: 1.77, MA20: 81.18, MA50: 81.47 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
kcphaeton
kcphaeton Apr. 13 at 1:19 PM
$EW i’m not sure what you’re smoking. Some of us have been holding a long time to see it. Get back to its all-time high. The all-time high closing price for Edwards Lifesciences (EW) was $130.68, which occurred on December 30, 2021.
1 · Reply
Ndellomo
Ndellomo Apr. 3 at 11:00 AM
$EW Edwards is a "buy and hold forever" type of company - just make sure you're not paying "hold forever" prices. Wait for Mr. Market to have one of his mood swings and offer you a better deal. https://stratafinance.beehiiv.com/p/edwards-lifesciences
1 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Mar. 11 at 3:47 AM
$AORT strong EBITDA growth and niche structural heart portfolio…. M&A 8x premium multiple ~$78 a share price target? Call me crazy but could be possible $MDT $BSC $EW $JNJ
1 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 2:57 PM
5 medical instrument stocks flashing serious short-term upside 👀 $ISRG $GMED $EW $ALC $IRMD are getting attention as AI tools, acquisitions, and new product pipelines fuel growth expectations — a combo that often sparks momentum in this space. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-teaser-36722&ADID=SYND_STOCKTWITS_TWEET_2_2881459_TEASER_36722
0 · Reply
ZacksResearch
ZacksResearch Mar. 10 at 1:57 PM
Five medical instrument stocks with significant short-term potential! 🚀 🤖 $ISRG leads the charge with AI-driven innovations, boasting a Zacks Rank #1 and a short-term price target indicating a 26% increase from its last close, with an upside of up to 52%. 💼 $GMED strengthens its position with strategic mergers, a debt-free balance sheet, and a promising pipeline, marked by a Zacks Rank #1 and a short-term target of a 24.7% gain, with an upside of up to 40.1%. 💔 $EW is advancing its Structural Heart business, supported by a Zacks Rank #2 and a short-term price target increase of 14%, with a maximum upside of 30.5%. 👓 $ALC capitalizes on its Vision Care innovations, with a Zacks Rank #2 and a short-term target increase of 13.9%, with an upside of up to 36.8%. 🩺 $IRMD expands with MRI-compatible products, holding a Zacks Rank #2 and a forecasted 19.9% rise, with an upside of 20%. Explore the full growth story here 👉 https://www.zacks.com/stock/news/2881459/5-medical-instruments-stocks-to-buy-amid-huge-short-term-price-upside?cid=sm-stocktwits-2-2881459-body-36721&ADID=SYND_STOCKTWITS_TWEET_2_2881459_BODY_36721
0 · Reply
GettnFibbywIT
GettnFibbywIT Mar. 5 at 4:25 PM
$EW $XLV $IHI Kryptonite is to Superman as the $87 ish area has been to Edwards...
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Mar. 1 at 2:42 AM
$MASI trading at $175 with volume slightly above average, while $EW sitting at $86 with volume significantly above average. MASI showing more strength with a higher price level compared to EW. MedicalTech sector heating up, will one outshine the other in the long run?
0 · Reply
PaulLaurent
PaulLaurent Feb. 26 at 7:28 AM
🔥 Breakout Scanner (4) — February 26, 2026 NFA. Risk: use 1–2% capital per trade. $CNP – Trigger 43.19 | SL 34.55 | Scores: F50 V41 G76 Q38 VAL56 (stable). News (24h): no fresh company-specific headline spotted. $EW – Trigger 83.50 | SL 66.80 | Scores: F49 V38 G40 Q66 VAL52 (stable). News (24h): filed annual Form 10-K. $PM – Trigger 190.00 | SL 152.00 | Scores: F59 V52 G55 Q69 VAL41 (stable). News (24h): no fresh company-specific headline spotted. $VST – Trigger 177.00 | SL 141.60 | Scores: F44 V50 G23 Q54 VAL56 (stable). News (24h): no fresh company-specific headline spotted.
0 · Reply